Press Releases ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 02:30:02 09/12/2025 am IST			5-day change	1st Jan Change
250.04 ^USD	-2.54%		+0.67%	+9.34%

07:12am	Shares of Resmed Fall After Securing FDA Clearance for a Device Recommending Personalized Comfort Settings	MT
08/12	ResMed Receives FDA Clearance for AI-Powered Device to Personalize Sleep Apnea Therapy	MT

Press Releases

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy	08/12	GL
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy	08/12	AQ
Major Breakthrough in At Home Sleep Therapy: ResMed Launches "AirCurve 11 VAuto" to Improve Sleep Apnea Treatment Comfort and Compliance	28/11	AQ
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	24/11	PU
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	24/11	PU
ResMed : Statement of Changes in Beneficial Ownership (Form 4)	24/11	PU
ResMed : 1Q26 Earnings Presentation	31/10	PU
ResMed : Earnings Release Q1 2026 PDF	31/10	PU
ResMed: Fiscal Q1 Earnings Snapshot	31/10	AQ
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026	31/10	GL
ResMed AirSense 11 AutoSet Redefines Sleep Apnea Treatment with Intelligent Pressure Adjustment, Cloud Connectivity, and Unmatched Comfort	29/10	AQ
Resmed : Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health in Australia	27/10	PU
ResMed's AirSense(TM) 11 CPAP Machines Revolutionize Sleep Apnea Treatment with Advanced Features and Enhanced Comfort	13/10	AQ
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025	10/10	GL
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025	10/10	AQ
Resmed : Showcases Leadership on Innovation, AI, and Patient-Centered Care at AdvaMed MedTech Conference	29/09	PU
The Future of Home Oxygen Therapy - The New Technological Advancements from Everflo and ResMed That Are Changing the Game	26/09	AQ
Resmed : Corporate Overview	19/09	PU
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025	17/09	GL
Resmed : Stewardship Presentation	13/09	PU
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority	04/09	GL
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds	27/08	GL
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds	27/08	AQ
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs	21/08	GL
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs	21/08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed's innovation-driven success and prospects

October 31, 2025 at 02:25 pm IST